Joseph Edelman, 10% Owner at Aldeyra Therapeutics, Inc. (ALDX), bought 355,986 shares at $4.67 ($1.7M) on 2024-04-04, disclosed to the SEC on 2024-04-08.
Open-market purchase of $1.7M ALDX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.67 | 140,281 | $655K | 39.3% |
| 2 | $4.67 | 140,281 | $655K | 39.3% |
| 3 | $4.74 | 37,712 | $179K | 10.7% |
| 4 | $4.74 | 37,712 | $179K | 10.7% |
| Total | $4.68 avg | 355,986 | $1.7M | 100% |
| Filing → |
| MGTX | BUY | 2024-08-14 | $5.0M | — | Filing → |
| ATHA | BUY | 2023-12-29 | $2.9M | — | Filing → |
| VRCA | BUY | 2023-12-29 | $4.6M | — | Filing → |